The world’s most important conference on basic, translational and clinical research related to cytokine biology

Cytokines & Interferons: From Biology to Clinics

Cytokine targeting has become one of the greatest revolutions in modern medicine. A large number of severe and sometimes even lethal inflammatory and autoimmune diseases have become manageable due to selective inhibition of cytokines and cytokine signaling. The development of compounds that selectively inhibit cytokines or interferons has permitted an so far unprecedented molecular characterization of human disease. Cytokines also contribute to cancer development and alterations in tissue homeostasis. Cytokines 2019 will address these developments and provide a comprehensive picture of the current knowledge of cytokine pathways in human disease and the strategies to inhibit, modulate or foster cytokine responses.  

Topics

  1. Mechanisms and treatment of inflammation: The IL-23/IL-17 pathway
  2. Biology and targeting of type 2-mediated immune responses
  3. Induction of immune tolerance –fact or fiction?
  4. Regulation of autoimmunity and autoimmune disease by cytokines
  5. Control of inflammation by inflammatory cytokines
  6. Cytokine-related diseases after checkpoint inhibition
  7. Immune metabolism regulating cytokine production and immune cell polarization
  8. Therapeutic targeting of the cytokine signaling pathways
  9. Targeting neutrophils and macrophages in immune-mediated disease
  10. Orchestration of inflammatory responses by IL-6
  11. Type I interferons: biology and their role is disease
  12. Novel aspects of IL-6 inhibition in disease
  13. Cytokine-mediated resident tissue destruction and fibrotic responses
  14. Local and systemic effects of IL-1 family cytokines in disease
  15. Innate Immunity – emerging topic session TBD

Program

CYTOKINES-2019-Preliminary-Program-as-of-May-9